1.12
price down icon1.75%   -0.02
after-market 시간 외 거래: 1.17 0.05 +4.46%
loading
전일 마감가:
$1.14
열려 있는:
$1.11
하루 거래량:
211.54K
Relative Volume:
0.74
시가총액:
$54.79M
수익:
-
순이익/손실:
$-56.85M
주가수익비율:
-0.7184
EPS:
-1.559
순현금흐름:
-
1주 성능:
-9.68%
1개월 성능:
-25.33%
6개월 성능:
-51.09%
1년 성능:
-85.03%
1일 변동 폭
Value
$1.07
$1.16
1주일 범위
Value
$1.07
$1.27
52주 변동 폭
Value
$1.07
$7.89

Fractyl Health Inc Stock (GUTS) Company Profile

Name
명칭
Fractyl Health Inc
Name
전화
781-902-8800
Name
주소
3 VAN DE GRAAFF DRIVE, BURLINGTON
Name
직원
107
Name
트위터
Name
다음 수익 날짜
2025-03-03
Name
최신 SEC 제출 서류
Name
GUTS's Discussions on Twitter

GUTS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GUTS
Fractyl Health Inc
1.12 54.79M 0 -56.85M 0 -1.559
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-02-28 개시 Evercore ISI Outperform
2024-02-27 개시 BofA Securities Buy
2024-02-27 개시 Morgan Stanley Overweight

Fractyl Health Inc 주식(GUTS)의 최신 뉴스

pulisher
Apr 02, 2025

Fractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025 - Insider Monkey

Apr 02, 2025
pulisher
Apr 02, 2025

10 Micro-Cap Stocks Insiders Were Buying in Q1 2025 - Insider Monkey

Apr 02, 2025
pulisher
Apr 01, 2025

Fractyl Health Reports Positive Early Data Showing Revita® - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation - The Manila Times

Apr 01, 2025
pulisher
Apr 01, 2025

Revolutionary Device Cuts Post-GLP-1 Weight Regain by 60% in Breakthrough Study - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Fractyl Health, Inc. (NASDAQ:GUTS) Shares Acquired by Bank of New York Mellon Corp - Defense World

Mar 31, 2025
pulisher
Mar 19, 2025

Fractyl Health director Barnes acquires $40,210 in common stock - Investing.com India

Mar 19, 2025
pulisher
Mar 18, 2025

Fractyl Health director Ajay Royan purchases $22,979 in common stock By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

Fractyl Health director Ajay Royan purchases $22,979 in common stock - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

FRACTYL HEALTH Executives Increase Their Stakes - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Fractyl Health director Barnes acquires $40,210 in common stock By Investing.com - Investing.com UK

Mar 18, 2025
pulisher
Mar 17, 2025

FRACTYL HEALTH Director Bradley William Acquires 16,129 Shares - TradingView

Mar 17, 2025
pulisher
Mar 13, 2025

Fractyl Health sets June 11 for 2025 stockholder meeting - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Fractyl Health sets June 11 for 2025 stockholder meeting By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 12, 2025

Rhumbline Advisers Boosts Stock Holdings in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World

Mar 12, 2025
pulisher
Mar 04, 2025

Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

Fractyl Health Reports 2024 Financial Results and Strategic Progress - MSN

Mar 04, 2025
pulisher
Mar 03, 2025

Earnings call transcript: Fractyl Health’s Q4 2024 results miss expectations, stock drops - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

FRACTYL HEALTH Earnings Results: $GUTS Reports Quarterly Earnings - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

Fractyl Health Highlights Urgent Demand for Weight Maintenance Solutions Post-GLP-1 Therapy in Upcoming REMAIN-1 Study Amid Strategic Focus on Metabolic Health - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Fractyl's Weight Maintenance Study Hits 189 Patients: Can It Solve the GLP-1 Rebound Problem? - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings Scheduled For March 3, 2025 - Benzinga

Mar 03, 2025
pulisher
Feb 24, 2025

Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025 - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Fractyl Health to Report Fourth Quarter and Full Year 2024 - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide ... - The Bakersfield Californian

Feb 24, 2025
pulisher
Feb 24, 2025

Can This Metabolic Disease Pioneer Deliver Strong Q4 Results? Fractyl Health Reports March 3 - StockTitan

Feb 24, 2025
pulisher
Feb 19, 2025

Fractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Drop in Short Interest - MarketBeat

Feb 19, 2025
pulisher
Feb 15, 2025

Stratos Wealth Partners LTD. Sells 21,148 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World

Feb 15, 2025
pulisher
Feb 12, 2025

After Plunging -19.55% in 4 Weeks, Here's Why the Trend Might Reverse for Fractyl Health, Inc. (GUTS) - Yahoo Finance

Feb 12, 2025
pulisher
Feb 10, 2025

Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - PharmaVoice

Feb 10, 2025
pulisher
Feb 07, 2025

Insider Selling: Fractyl Health, Inc. (NASDAQ:GUTS) CEO Sells 90,972 Shares of Stock - MarketBeat

Feb 07, 2025
pulisher
Feb 07, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 07, 2025
pulisher
Feb 07, 2025

Fractyl Health (NASDAQ:GUTS) Price Target Cut to $10.00 by Analysts at Morgan Stanley - MarketBeat

Feb 07, 2025
pulisher
Feb 05, 2025

Potential Price Increase for Fractyl Health Inc (GUTS) After Recent Insider Activity - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

BlackRock, Inc. Increases Stake in Fractyl Health Inc: A Strategic Move in Biotechnology - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Fractyl Health, Inc. (NASDAQ:GUTS) Stock Position Lifted by JPMorgan Chase & Co. - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Fractyl Health, Inc. (NASDAQ:GUTS) Insider Jay David Caplan Sells 22,346 Shares - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Fractyl Health Inc (GUTS) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Trading Day Triumph: Fractyl Health Inc (GUTS) Ends at 1.70, a -7.61 Surge/Plunge - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Fractyl Health (NASDAQ:GUTS) Given New $10.00 Price Target at Morgan Stanley - Defense World

Feb 04, 2025
pulisher
Feb 03, 2025

FRACTYL HEALTH Executives Sell Shares - TradingView

Feb 03, 2025
pulisher
Feb 03, 2025

Fractyl Health announces layoffs as it pivots to gene therapy - Mass Device

Feb 03, 2025
pulisher
Jan 31, 2025

Burlington biotech company announces layoffs, pivots research focus - NBC Boston

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health Announces Increased Focus on Groundbreaking - GlobeNewswire

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health pivots Type 2 diabetes device therapy toward obesity and GLP-1s, lays off 17% of staff - Fierce Biotech

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health To Focus On Revita, Rejuva Programs, To Cut Workforce By 17%; Stock Down - Nasdaq

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health announces increased focus on Revita, Rejuva programs - TipRanks

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health Reprioritizes Focus on REMAIN-1 Study - TipRanks

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health Prioritizes Clinical Development of Revita and Advances Rejuva Gene Therapy in Response to Market Demand - Nasdaq

Jan 31, 2025

Fractyl Health Inc (GUTS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):